Get the Stockscreener App
2.99
0.99%
-0.03
Pre-market:
2.97
-0.02
-0.67%
Painreform Ltd stock is traded at $2.99, with a volume of 44,897.
It is down -0.99% in the last 24 hours and down -43.58% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$3.02
Open:
$2.96
24h Volume:
44,897
Relative Volume:
0.01
Market Cap:
$2.62M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.4188
EPS:
-7.14
Net Cash Flow:
$-6.69M
1W Performance:
+9.12%
1M Performance:
-43.58%
6M Performance:
-75.33%
1Y Performance:
-94.45%
1-Day Range:
$2.90
$3.06
1-Week Range:
$2.74
$3.32
52-Week Range:
$1.7272
$61.20
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
2.99 | 2.62M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Painreform Ltd Stock (PRFX) Latest News
PainReform (NASDAQ:PRFX) Stock Price Down 3.6% – What’s Next? - Defense World
PainReform Ltd. Gains $3.17 Million from Warrant Exercise - TipRanks
Maxim Group Downgrades PainReform (PRFX) - MSN
PainReform Faces Setback in Phase 3 Trial for PRF-110 - Yahoo Finance
Stock market news: Siyata Mobile -90.00%, PainReform -29.18% among biggest losers during mid day trading - Business Upturn
PainReform Ltd. Provides Further Update on Phase 3 Clinical Trial of PRF-110 - Marketscreener.com
PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110 - GlobeNewswire
PainReform's PRF-110 Trial Shows Mixed Results: Strong 48-Hour Pain Relief But Misses Primary Endpoint - StockTitan
Wall Street Holidays next week: NYSE, Nasdaq to remain closed on THESE days - Qrius
Cronos Group (CRON) Stock Surges Over 5% Amid Market Activity - GuruFocus.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.18% - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.18% - Investing.com UK
Dow Surges 100 Points, Carnival Earnings Top Views - Benzinga
BP and Iraq agree on technical terms for Kirkuk oilfield redevelopment - Yahoo! Voices
Skechers expands presence in Czech Republic with new concept store - Yahoo! Voices
Why the dollar is the most decentralized currency - Yahoo Finance
Fed's hawkish tilt has emerging markets scurrying to save currencies - Yahoo Canada Finance
Siga Technologies (SIGA) Stock Surges Over 5% Amid Market Activi - GuruFocus.com
Lamb Weston stock fried over Q2 miss, guidance cut, new CEO - Yahoo Finance
Wall Street-Heavily Traded - WDRB
Mortgage rates perk up, snapping three weeks of declines - Yahoo Finance
The trade controls US could enact while navigating China chip war - Yahoo Finance
Bitcoin drops after Powell says Federal Reserve 'not allowed' to own the cryptocurrency - Yahoo! Voices
Fed cuts reverse repo rate by wider margin than funds rate target - Yahoo Canada Finance
Current economy won't 'allow for a proper easing cycle': Economist - Yahoo Finance
Nasdaq, 'super-bullish' sentiment, bitcoin: Market Takeaways - Yahoo Finance
Stock market today: Wall Street trims its stellar gains as Nvidia's star dims again - Yahoo Canada Finance
Broadcom stock eases on post-earnings rally as Nvidia tumbles - Yahoo Finance
Air Canada eyes strong revenue growth by 2028, banks on robust leisure travel demand - Yahoo Canada Finance
Natural gas stocks are this expert's top pick, not 'overvalued' tech stocks - Yahoo Finance
Retail sales data, YF's Surprise of the Year: What to Watch - Yahoo Finance
Nasdaq notches record close as investors await Fed rate decision - Yahoo Finance
US to require passenger vehicles to sound alarms if rear passengers don't fasten their seat belts - Yahoo Canada Finance
What the Fed's next cut could mean for high-yield bonds - Yahoo Finance
Nvidia vs. Broadcom: What Wall Street says about the chip stocks - Yahoo Finance
3 Dividend Stocks to Double Up on Right Now - Yahoo Canada Finance
Tesla price target bumped up to $515 by Wedbush - Yahoo Finance
It’s all fun and meme coins, until the markets turn - Yahoo Canada Finance
Nespresso North America's CEO "actually knocked on Nestlé's door" to get his first job - Yahoo Finance
Federal Reserve is likely to slow its rate cuts with inflation pressures still elevated - Yahoo Canada Finance
South Korea Impeached President Yoon Suk Yeol. What Happens Next? - Yahoo Finance
Why there may be more market volatility ahead - Yahoo Finance
Ottawa to remove 30% investment cap for Canadian pension funds - Yahoo Canada Finance
Air Canada introducing contested carry-on bag fee to stay competitive, executive says - Yahoo Canada Finance
Musk's SEC feud, tech rally, Broadcom earnings: 3 Things - Yahoo Finance
Summit Financial buys Midway Wealth Partners - Yahoo News
What ServiceTitan's Nasdaq debut signals for the IPO market in 2025 - Yahoo Finance
Mets sign Juan Soto, WNBA expansion draft: YF Sports Report - Yahoo Finance
The Smartest Dividend Stocks to Buy With $500 Right Now - Yahoo Canada Finance
There's only 2 Magnificent 7 names this strategist likes for 2025 - Yahoo Finance
Explainer-What next for Nippon Steel and US Steel's $15 billion mega-merger? - Yahoo Canada Finance
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):